We’re proud to announce the second peer-reviewed publication of our Phase 1 study on 3-MMC, [...]
Introduction Last week, we shared how science often misrepresents the real harms — and real potentials [...]
Introduction When we talk about drugs, conversations are often shaped by stigma and policy, not science. [...]
We are incredibly proud to share that our Phase 1 study has been published in Nature, [...]
Premenstrual Dysphoric Disorder is a severe condition affecting millions of women worldwide, yet it remains underdiagnosed [...]
